Remiges Ventures, Inc.
Life-science venture firm investing in and forming drug-discovery companies in the US and Japan, with an incubation subsidiary, RDiscovery, for pre-startup translation and venture formation.
Remiges Ventures, Inc. is a life-science venture firm focused on drug discovery and drug development. Its work spans both investment in existing companies and the formation of new ones, with an emphasis on bridging early-stage drug discovery to the expertise, capital and commercial pathways required for further development. The firm's stated mission is to advance drug-discovery opportunities toward global development and patient benefit.
Company creation is a core element of the model. RDiscovery, a wholly owned incubation subsidiary, supports the pre-startup translation of scientific discoveries, the creation of new intellectual property and the formation of ventures intended to move drug-discovery opportunities toward global development. This places the firm's activity upstream of conventional venture investing, at the point where seed technologies and academic results are converted into therapeutic ventures.
Remiges operates across the United States and Japan, combining US entrepreneurship and biotech networks with Japanese academic life-science innovation. The firm supports the early development of therapeutic ventures in Japan and internationally, and its stated technical domains include drug discovery and development, translational science, intellectual-property creation and seed technology commercialization. Relevant industry verticals span biotechnology, pharmaceuticals, drug discovery and development, and academia and technology transfer.